コンテンツへスキップ
Merck

Alternative delivery of a thermostable inactivated polio vaccine.

Vaccine (2015-03-17)
Heleen Kraan, Ivo Ploemen, Gijsbert van de Wijdeven, Ivo Que, Clemens Löwik, Gideon Kersten, Jean-Pierre Amorij
要旨

In the near future oral polio vaccine (OPV) will be replaced by inactivated polio vaccine (IPV) as part of the eradication program of polio. For that reason, there is a need for substantial amount of safe and more affordable IPV for low-income countries. Bioneedles, which are biodegradable mini-implants, have the potential to deliver vaccines outside the cold-chain and administer them without the use of needles and syringes. In the current study, Bioneedles were filled with IPV, subsequently lyophilized, and antigenic recoveries were determined both directly after IPV-Bioneedle preparation as well as after elevated stability testing. Further, we assessed the immunogenicity of IPV-Bioneedles in rats and the residence time at the site of administration. Trivalent IPV was formulated in Bioneedles with recoveries of 101±10%, 113±18%, and 92±15%, respectively for serotypes 1, 2 and 3. IPV in Bioneedles is more resistant to elevated temperatures than liquid IPV: liquid IPV retained less than half of its antigenicity after 1 day at 45°C and IPV in Bioneedles showed remaining recoveries of 80±10%, 85±4% and 63±4% for the three serotypes. In vivo imaging revealed that IPV administered via Bioneedles as well as subcutaneously injected liquid IPV showed a retention time of 3 days at the site of administration. Finally, an immunogenicity study showed that IPV-filled Bioneedles are able to induce virus-neutralizing antibody titers similar to those obtained by liquid intramuscular injection when administered in a booster regime. The addition of LPS-derivate PagL in IPV-filled Bioneedles did not increase immunogenicity compared to IPV-Bioneedles without adjuvant. The current study demonstrates the pre-clinical proof of concept of IPV-filled Bioneedles as a syringe-free alternative delivery system. Further pre-clinical and clinical studies will be required to assess the feasibility whether IPV-Bioneedles show sufficient safety and efficacy, and may contribute to the efforts to eradicate and prevent polio in the future.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
塩化マグネシウム 六水和物, ACS reagent, 99.0-102.0%
Sigma-Aldrich
D-ソルビトール, ≥98% (GC)
Sigma-Aldrich
クエン酸, meets analytical specification of Ph. Eur., BP, USP, E330, anhydrous, 99.5-100.5% (based on anhydrous substance)
Sigma-Aldrich
塩化マグネシウム 六水和物, ReagentPlus®, ≥99.0%
Sigma-Aldrich
塩化マグネシウム 六水和物, puriss., meets analytical specification of Ph. Eur., BP, FCC, E511, 99-101%, ≤0.0001% Al
Sigma-Aldrich
D-ソルビトール, BioUltra, ≥99.0% (HPLC)
Sigma-Aldrich
D-ソルビトール, 99% (GC)
Sigma-Aldrich
D-ソルビトール, ≥98% (GC), for molecular biology
Sigma-Aldrich
塩化マグネシウム 六水和物, BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
クエン酸, ≥99.5%, FCC, FG
Sigma-Aldrich
クエン酸, anhydrous, suitable for cell culture, suitable for plant cell culture
USP
ソルビトール, United States Pharmacopeia (USP) Reference Standard
USP
クエン酸, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
D-ソルビトール, ≥98% (GC), BioReagent, suitable for cell culture, suitable for plant cell culture
Sigma-Aldrich
クエン酸, BioUltra, anhydrous, ≥99.5% (T)
Sigma-Aldrich
クエン酸, ACS reagent, ≥99.5%
Sigma-Aldrich
ソルビトール F 溶液, 70 wt. % in H2O, Contains mainly D-sorbitol with lesser amounts of other hydrogenated oligosaccharides
Sigma-Aldrich
クエン酸, 99%
Sigma-Aldrich
D-ソルビトール, FCC, FG
Sigma-Aldrich
2-Hydroxybutyric acid sodium salt, 97%
Sigma-Aldrich
D-ソルビトール, ≥98% (GC), BioXtra
Sigma-Aldrich
塩化マグネシウム 六水和物, 99.995% trace metals basis
Sigma-Aldrich
塩化マグネシウム 六水和物, BioXtra, ≥99.0%
Supelco
クエン酸、無水, Pharmaceutical Secondary Standard; Certified Reference Material
Supelco
ソルビトール, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
クエン酸, anhydrous, free-flowing, Redi-Dri, ACS reagent, ≥99.5%
Sigma-Aldrich
塩化マグネシウム 六水和物, BioUltra, for molecular biology, ≥99.0% (KT)
Sigma-Aldrich
クエン酸, SAJ first grade, ≥99.5%
Supelco
クエン酸, certified reference material, TraceCERT®, Manufactured by: Sigma-Aldrich Production GmbH, Switzerland
ソルビトール, European Pharmacopoeia (EP) Reference Standard